Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2
about
Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routesHSV-2: in pursuit of a vaccineHerpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculationCharacterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization.Recent progress in herpes simplex virus immunobiology and vaccine researchHerpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease.Unique features of antiviral immune system of the vaginal mucosaReplication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cellsVirus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice.Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model.Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.Immunity to vaginal herpes simplex virus-2 infection in B-cell knockout mice.Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2.
P2860
Q22241377-ECCA906D-9847-4E62-AC08-0BD7BEB132BCQ22306291-65335142-43A7-4572-BEA0-29AACC0C9731Q33625030-6337FC06-F68B-40DE-93BE-E582DF7738E5Q33788701-AE7D6589-4EB3-49FA-8545-1158B45D89C5Q33788861-011DC1CC-5C4D-4B2F-8322-780E3AD059C9Q33853571-D3BBC5A7-F76F-4988-A95D-9AD8DE51F79FQ33963713-575D32BA-26EB-4D0A-A1F3-506F2F6A570BQ35156674-C06833AD-980B-42E1-9452-41D7EF0FDD2DQ35802953-2C9E6526-23DC-4A9E-B305-881D4634F8B6Q36155337-0630E65B-9E28-449E-AF4F-9D7591229539Q36177229-518CF320-35C8-4CD0-B0A4-9F868B8F42B8Q36728688-2C883FD4-1FC4-4F48-B49F-A0FEECEDD1CEQ37101184-AB86BFDC-28AA-40A2-9336-B76389E20551Q37365361-133FEB3B-8D5D-46EF-9291-DBAC50BE1320Q37627859-97896E2A-F5DE-4F93-A977-ABDE4BCCA8B2Q45740405-CC1F518B-FE27-432A-85DC-7B545BEA061BQ45745771-0594EA38-4221-48F6-B2F4-08A21B0E9749
P2860
Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Immunoglobulin G, plasma cells ...... ed herpes simplex virus type 2
@ast
Immunoglobulin G, plasma cells ...... ed herpes simplex virus type 2
@en
type
label
Immunoglobulin G, plasma cells ...... ed herpes simplex virus type 2
@ast
Immunoglobulin G, plasma cells ...... ed herpes simplex virus type 2
@en
prefLabel
Immunoglobulin G, plasma cells ...... ed herpes simplex virus type 2
@ast
Immunoglobulin G, plasma cells ...... ed herpes simplex virus type 2
@en
P2860
P1433
P1476
Immunoglobulin G, plasma cells ...... ed herpes simplex virus type 2
@en
P2093
P2860
P304
P577
1998-06-01T00:00:00Z